Target Name: LTF
NCBI ID: G4057
Review Report on LTF Target / Biomarker Content of Review Report on LTF Target / Biomarker
LTF
Other Name(s): Lfcin-H | Lactoferroxin | growth-inhibiting protein 12 | lactoferricin | Lactoferroxin-B | Neutrophil lactoferrin | talalactoferrin | GIG12 | HLF2 | lactoferroxin | Lactoferroxin-A | Lactotransferrin | neutrophil lactoferrin | Lactoferrin | Epididymis luminal protein 110 | Lactotransferrin, transcript variant 1 | LTF variant 1 | Lactoferroxin-C | Lactoferricin | Talalactoferrin | Lactotransferrin (isoform 1) | Lactoferricin-H | Growth-inhibiting protein 12 | LF | epididymis luminal protein 110 | TRFL_HUMAN | kaliocin-1 | lactotransferrin | Kaliocin-1 | HEL110

LTF: A Protein Interacts with Drugs and Regulates Cell Processes

LTF (Lfcin-H), also known as Leucine-rich repeat-containing protein 1, is a protein that is expressed in various tissues and cells throughout the body. It is characterized by the presence of a unique repeat sequence, known as a leucine -rich repeat, which is found in approximately 20% of all human proteins.

Recent studies have identified LTF as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to LTF's unique structure, which has been shown to interact with a variety of molecules, including drugs, toxins , and diseases.

One of the key mechanisms by which LTF has been shown to interact with drugs is its role in cellular signaling. LTF has been shown to play a role in the regulation of cell growth, differentiation, and survival, as well as in the regulation of inflammation and immune responses. This makes it an attractive target for drugs that are designed to intervene in these processes.

In addition to its role in cellular signaling, LTF has also been shown to play a key role in the regulation of protein synthesis and degradation. This is important because changes in the levels of protein synthesis and degradation can have a significant impact on the health and disease of cells.

Another mechanism by which LTF has been shown to interact with drugs is its role in the regulation of cellular transport. LTF has been shown to play a role in the regulation of protein transport into and out of cells, which can have a significant impact on the levels of intracellular and extracellular proteins.

In conclusion, LTF is a protein that has been shown to interact with a variety of molecules and to play a role in the regulation of cellular signaling, protein synthesis and degradation, and transport. This makes it an attractive target for drugs that are designed to intervene in these processes. Further research is needed to fully understand the mechanisms by which LTF interacts with drugs and to develop effective treatments for diseases that are dependent on its function.

Protein Name: Lactotransferrin

Functions: Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate

The "LTF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LTF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LTK | LTN1 | LTO1 | LTV1 | LUADT1 | LUC7L | LUC7L2 | LUC7L3 | LUCAT1 | LUM | LUNAR1 | LURAP1 | LURAP1L | LURAP1L-AS1 | Luteinizing hormone | LUZP1 | LUZP2 | LUZP4 | LUZP6 | LVRN | LXN | LY6D | LY6E | LY6E-DT | LY6G5B | LY6G5C | LY6G6C | LY6G6D | LY6G6E | LY6G6F | LY6H | LY6K | LY75 | LY75-CD302 | LY86 | LY86-AS1 | LY9 | LY96 | LYAR | LYG1 | LYG2 | LYL1 | Lymphocyte antigen 6 complex | LYN | LYNX1 | LYPD1 | LYPD2 | LYPD3 | LYPD4 | LYPD5 | LYPD6 | LYPD6B | LYPD8 | LYPLA1 | LYPLA2 | LYPLA2P1 | LYPLA2P2 | LYPLAL1 | LYPLAL1-AS1 | LYRM1 | LYRM2 | LYRM4 | LYRM4-AS1 | LYRM7 | LYRM9 | LYSET | Lysine-Specific Demethylase 3 | Lysine-specific demethylase 5 | LYSMD1 | LYSMD2 | LYSMD3 | LYSMD4 | Lysophospholipid (edg) Receptors | LYST | Lysyl Oxidase Homolog | LYVE1 | LYZ | LYZL1 | LYZL2 | LYZL4 | LYZL6 | LZIC | LZTFL1 | LZTR1 | LZTS1 | LZTS1-AS1 | LZTS2 | LZTS3 | m-Calpain | M1AP | M6PR | MAB21L1 | MAB21L2 | MAB21L3 | MAB21L4 | MACC1 | MACC1-DT | MACF1 | MACIR | MACO1